Highlights Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Real-time Estimate Cboe BZX Other stock markets 11:40:44 14/05/2024 pm IST			5-day change	1st Jan Change
5.075 ^USD	+12.03%		-54.18%	-60.04%

08/05	Top Midday Decliners	MT
08/05	UBS Adjusts Price Target on Treace Medical Concepts to $16 From $17, Maintains Buy Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Top Midday Decliners	09/05	MT
Truist Downgrades Treace Medical Concepts to Hold From Buy, Cuts PT to $7 From $17; Notes Slowing Growth Outlook Amid Rising Competitive Pressures	08/05	MT
Top Premarket Decliners	08/05	MT
Treace Medical Concepts Falls 57% Premarket After Revising 2024 Sales Outlook to $201-$211 Million From $220-$225 Million	08/05	MT
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q1 Revenue $51.1M, vs. Street Est of $49.1M	08/05	MT
Treace Medical Concepts, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Treace Medical Concepts, Inc. Revises Earnings Guidance for the Full-Year 2024	08/05	CI
Treace Medical Concepts Treats 100,000 Patients With Lapiplasty Bunion Correction	25/03	MT
Treace Medical Concepts, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/02	CI
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Reports Q4 Revenue $62.2M, vs. Street Est of $60.2M	28/02	MT
Treace Medical Concepts, Inc. Provides Revenue Guidance for the Year 2024	28/02	CI
Treace Medical Concepts, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/02	CI
Treace Medical Concepts, Inc. Announces Three-Year Interim Data from Its Align3d?? Post-Market Study Supporting the Use of the Lapiplasty Procedure for Treating Bunions	02/02	CI
Treace Medical Concepts Q3 Adjusted Loss Widens, Revenue Rises; Lowers Annual Revenue Outlook	10/11	MT
Earnings Flash (TMCI) TREACE MEDICAL CONCEPTS Posts Q3 Revenue $40.8M, vs. Street Est of $42.1M	10/11	MT
Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
Treace Medical Concepts, Inc. Revises Revenue Guidance for the Year 2023	10/11	CI
Treace Medical Concepts, Inc. Highlights New Product Innovations and Updated Align3d Clinical Study Data At the American Orthopaedic Foot & Ankle Society Annual Meeting 2023	20/23/20	CI
Treace Medical Concepts, Inc. Announces Limited Market Release of New Complementary Technologies for Treating Bunions and Related Procedures	12/23/12	CI
Treace Medical Concepts Q2 Adjusted Loss Narrows, Revenue Rises; 2023 Revenue Outlook Lifted	09/23/09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Treace Medical Concepts, Inc.

Equities

TMCI

US89455T1097

Highlights

Filters